NTRK2 and central nervous system cancer: BDNF has direct effects on the glioma, mediating the functional effects observed on M/Mφ but also reducing the chemotactic activity of tumour cells through activation of TrkB.T1 receptor and inhibition of RhoA signalling, as previously shown35.